These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 17020540

  • 1. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment.
    Hou YP, Wu JL, Fan Q, Liu MB, Yin BL, Zhang L.
    Clin Sci (Lond); 2007 Mar; 112(5):299-304. PubMed ID: 17020540
    [Abstract] [Full Text] [Related]

  • 2. Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment.
    Miao GB, Liu JC, Liu MB, Wu JL, Zhang G, Chang J, Zhang L.
    Eur J Clin Invest; 2006 Sep; 36(9):614-20. PubMed ID: 16919043
    [Abstract] [Full Text] [Related]

  • 3. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A, Aronow WS, Vadnerkar A, Sivan K, Mittal S.
    Am J Ther; 2009 Sep; 16(1):5-7. PubMed ID: 19142162
    [Abstract] [Full Text] [Related]

  • 4. Influence of digitalis on left ventricular functional response to exercise in congestive heart failure.
    Morisco C, Cuocolo A, Romano M, Nappi A, Iaccarino G, Volpe M, Salvatore M, Trimarco B.
    Am J Cardiol; 1996 Mar 01; 77(7):480-5. PubMed ID: 8629588
    [Abstract] [Full Text] [Related]

  • 5. Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure.
    Kourea K, Parissis JT, Farmakis D, Panou F, Paraskevaidis I, Venetsanou K, Filippatos G, Kremastinos DT.
    Atherosclerosis; 2008 Jul 01; 199(1):215-21. PubMed ID: 17991471
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.
    Kalman J, Buchholz C, Steinmetz M, Courtney M, Gass A, Lansman S, Kukin ML.
    J Heart Lung Transplant; 1995 Jul 01; 14(6 Pt 1):1212-7. PubMed ID: 8719469
    [Abstract] [Full Text] [Related]

  • 7. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS.
    J Lab Clin Med; 2001 May 01; 137(5):316-23. PubMed ID: 11329528
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
    Majumdar SR, McAlister FA, Cree M, Chang WC, Packer M, Armstrong PW, ATLAS Study Group.
    Clin Ther; 2004 May 01; 26(5):694-703. PubMed ID: 15220013
    [Abstract] [Full Text] [Related]

  • 10. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.
    Adamopoulos S, Parissis J, Karatzas D, Kroupis C, Georgiadis M, Karavolias G, Paraskevaidis J, Koniavitou K, Coats AJ, Kremastinos DT.
    J Am Coll Cardiol; 2002 Feb 20; 39(4):653-63. PubMed ID: 11849865
    [Abstract] [Full Text] [Related]

  • 11. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2].
    Skvortsov AA, Mareev VIu, Nasonova SN, Sychev AV, Arbolishvili GN, Baklanova NA, Masenko VP, Belenkov IuN.
    Ter Arkh; 2006 Feb 20; 78(9):61-71. PubMed ID: 17076227
    [Abstract] [Full Text] [Related]

  • 12. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
    Gheorghiade M, Hall VB, Jacobsen G, Alam M, Rosman H, Goldstein S.
    Circulation; 1995 Oct 01; 92(7):1801-7. PubMed ID: 7671364
    [Abstract] [Full Text] [Related]

  • 13. [Efficacy and safety of long-term application of spironolactone in patients with moderate and severe chronic heart failure receiving optimal therapy].
    Skvortsov AA, Mareev VY, Chelmakina SM, Baklanova NA, Belenkov IuN.
    Kardiologiia; 2007 Oct 01; 47(10):12-23. PubMed ID: 18260939
    [Abstract] [Full Text] [Related]

  • 14. [Role of soluble Fas ligand in myocardial remodeling, severity and outcomes of chronic heart failure].
    Teplyakov AT, Berezikova EN, Shilov SN, Grakova EV, Torim YY, Efremov AV, Popova AA, Pustovetova MG, Sabirova AY, Kopyeva KV.
    Ter Arkh; 2016 Oct 01; 88(9):10-16. PubMed ID: 27735908
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone-induced reduction of soluble apoptosis mediators is associated with reverse cardiac remodelling and improvement of exercise capacity in patients with idiopathic dilated cardiomyopathy.
    Parissis JT, Adamopoulos S, Karatzas D, Paraskevaidis J, Livanis E, Kremastinos D.
    Eur J Cardiovasc Prev Rehabil; 2005 Apr 01; 12(2):164-8. PubMed ID: 15785303
    [Abstract] [Full Text] [Related]

  • 16. Cellular basis for improved left ventricular pump function after digoxin therapy in experimental left ventricular failure.
    McMahon WS, Holzgrefe HH, Walker JD, Mukherjee R, Arthur SR, Cavallo MJ, Child MJ, Spinale FG.
    J Am Coll Cardiol; 1996 Aug 01; 28(2):495-505. PubMed ID: 8800131
    [Abstract] [Full Text] [Related]

  • 17. [Pharmacologic treatment of chronic congestive heart failure].
    Halawa B.
    Przegl Lek; 1996 Aug 01; 53(3):119-23. PubMed ID: 8754362
    [Abstract] [Full Text] [Related]

  • 18. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B.
    Pol Merkur Lekarski; 1999 Mar 01; 6(33):152-6. PubMed ID: 10365602
    [Abstract] [Full Text] [Related]

  • 19. Congestive heart failure and ventricular arrhythmias in relation to serum magnesium.
    Oladapo OO, Falase AO.
    Afr J Med Med Sci; 2000 Mar 01; 29(3-4):265-8. PubMed ID: 11714003
    [Abstract] [Full Text] [Related]

  • 20. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia.
    Adigun AQ, Ajayi AA.
    Eur J Heart Fail; 2001 Jun 01; 3(3):359-63. PubMed ID: 11378008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.